Phase II vaccination: 27,000 residents in Enugu receive COVID-19 vaccine



The Enugu State Government says no fewer than 27,000 residents have so far received -19 vaccines in the second phase of the nationwide vaccination.


Dr George Ugwu, Executive Secretary of Enugu State Primary Health Care Development Agency (ENS-PHCDA), disclosed this on Saturday when newsmen on the of the -19 vaccination in the state.


Ugwu said that the -19 vaccination, which is side-by-side and simultaneously with other routine and special vaccinations in the state, had so far been hitch free.


said that the residents were administered with Modena and Astra Zeneca -19 vaccines.


According to Ugwu, more residents are already embracing getting their jabs after intensive mobilisation and sensitisation on the overwhelming benefits of the -19 vaccine to families and communities.


“We have administered a total of 27,000 residents in the second phase and the exercise has been hitch-free and without any adverse health effect recorded.


“After the first phase, we restrategised on our and mobilisation plans and it is paying off.


“Our committees at state, zonal, local, community and ward levels have shown serious commitment and they spear no social gathering in heralding the need for all to get protected at the same time,” said.


The executive secretary also enjoined residents that have not received their -19 vaccines quickly do so to avoid rush as well as get themselves, families, friends and communities protected the pandemic.


The News Agency of Nigeria (NAN) recalls that Gov. Ifeanyi Ugwuanyi flagged off -19 second phase vaccination at the Enugu State University Teaching Hospital, Enugu, on Aug. 26.


The state has received 5,012 doses of Modena vaccine and additional 13,416 doses of Astra Zeneca vaccines. It is expecting an additional 60,000 doses of Modena vaccine.


A total of 1,200 health workers have been specially trained to vaccinate people in the second phase of the exercise.


Enugu State had already exhausted the 65,410 doses of Astra Zeneca vaccines supplied by the National Primary Healthcare Development Agency in March, 2021 first phase of the vaccination. (NAN)